The two most commonly used DAAs are combination drugs: Mavyret (glecaprevir /pibrentasvir). Mavyret was first approved by the ...

Scientists have yet to find a cure for this potentially severe form of viral hepatitis, which affects anywhere from 2.4 ...

Australia's goal of removing hepatitis C from the population is under threat. It is estimated 70,000 Australians have the virus but many of them do not know it. Hepatitis C crept up slowly on ...

The CDC estimates that more than 2.4 million people had hepatitis C from 2017 through 2020. However, since many people with ...

Hepatitis C vaccine development can be accelerated now that cryo-electron microscopy has revealed new details about the virus ...

It is also the eighth installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious human disease. You may read the others on Forbes or www.williamhaseltine.com.

While their discovery solved a decades-long scientific mystery and provided hope for many diagnosed with the disease, the ...

offering a cure for most individuals with chronic HCV, thereby preventing the progression to cirrhosis and HCC. cure from ...

Liver failure (end-stage liver disease). This can take months or ... and damage caused by an infection with the hepatitis C virus. Many people have the virus without realizing it, as it doesn ...

Scientists have identified the protein complex that gives the hepatitis C virus the ability to bind and infect cells.

The diagnosis of hepatitis A virus (HAV) infection is based on the ... system due to unrelated viral infection or autoimmune diseases. Molecular diagnosis of HAV along with anti-HAV IgG avidity ...

Phylogenetic analysis of acute and fulminant hepatitis A cases confirmed that genotype IIIA was predominant over IA, with no link between genotype and disease severity. There was a similar ...